FDA clears higher-dose Wegovy injections for obesity treatment

TL;DR Summary
The FDA has approved a higher-dose Wegovy (semaglutide) injectable for obesity treatment, expanding weekly dosing options to help with weight management amid ongoing efforts to address obesity-related health risks.
- FDA approves new higher-dose version of Wegovy shots AP News
- Weight-loss treatment is on the verge of a dramatic shift – again CNN
- FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share CNBC
- Novo’s High-Dose Wegovy Gets US Approval in Needed Boost Bloomberg.com
- FDA approves higher dose of Wegovy The Hill
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
14 min
vs 14 min read
Condensed
99%
2,794 → 29 words
Want the full story? Read the original article
Read on AP News